https://www.selleckchem.com/products/peg300.html
6 for KSKS. The MCID determined by anchor-based ROC was between 15 and 20 for KSFS (AUC satisfaction=71.8%, survivorship=61.4%) and between 33 and 34 for KSKS (AUC satisfaction=76.3%, survivorship=67.1%). The MCID determined by distribution-based method of 0.5 SD was 11.7 for KSFS and 11.9 for KSKS. The MCID of 6.3 points for KSFS, and 6.6 points for KSKS, is a useful benchmark for future studies looking to compare revision against primary TKA outcomes. Clinically, the MCID between 15 and 20 for KSFS and between 33 and 34 for KSKS is a p
Like
Comment
Share
